Trastuzumab emtansine (T-DM1)-associated cardiotoxicity: Pooled analysis in advanced HER2-positive breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Trastuzumab emtansine (T-DM1)-associated cardiotoxicity: Pooled analysis in advanced HER2-positive breast cancer

Published:2020-02 Issue: Volume:126 Page:65-73
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Pondé Noam,Ameye Lieveke,Lambertini Matteo,Paesmans Marianne,Piccart Martine,de Azambuja Evandro

Funder

Les Amis de L'institut Bordet

AstraZeneca

Novartis

Roche

Genentech

Lilly

MSD

Pfizer

Servier

GSK

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference28 articles.

1. Trastuzumab emtansine: a unique antibody-drug conjugate in development for human epidermal growth factor receptor 2-positive cancer;LoRusso;Clin Cancer Res Off J Am Assoc Cancer Res,2011

2. Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA;Krop;Ann Oncol,2015

3. Trastuzumab emtansine for HER2-positive advanced breast cancer;Verma;N Engl J Med,2012

4. Trastuzumab emtansine versus treatment of physician’s choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trial;Krop;Lancet Oncol,2017

5. Trastuzumab emtansine versus treatment of physician’s choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial;Krop;Lancet Oncol,2014

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breast Cancer Immunotherapy: A Clinical Review for the Plastic Surgeon;Plastic and Reconstructive Surgery - Global Open;2024-06

2. Safety Profile of the Trastuzumab-Based ADCs: Analysis of Real-World Data Registered in EudraVigilance;Biomedicines;2024-04-25

3. Cardiotoxicity of Agents Used in Patients With Breast Cancer;JCO Oncology Practice;2024-01

4. Incidence of HER2-targeted antibody-drug conjugates-related cardiac events: a meta-analysis;Journal of Cancer;2024

5. VAR2HP recognizing heparin‐like epitopes in targeted therapy and diagnosis of tumors;Proteoglycan Research;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3